Shares of Moderna dropped 4.99% to $139.87 at 09:53 EST on Wednesday, following yesterday’s downward trend. The Nasdaq Stock Market is jumping 1.25% to $12,595.10, after two consecutive sessions in a row of gains. This seems, at the moment, an all-around positive trend trading session today.
Moderna’s last close was $155.07, 27.62% under its 52-week high of $178.50.
News about Moderna today
Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to today’s article on CNBC, "Moderna (MRNA) – Moderna was downgraded to "hold" from "buy" at Jefferies, which cited the significant runup in the drugmaker’s stock as well as high expectations surrounding its Covid-19 vaccine. "
Moderna’s sales growth is 1428.1% for the ongoing quarter and 13065.3% for the next. The company’s growth estimates for the present quarter is a negative 48.6% and positive 565.7% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is valued at $139.87 at 09:53 EST, way under its 52-week high of $178.50 and way higher than its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s worth is way higher than its 50-day moving average of $106.15 and way above its 200-day moving average of $77.98.
Previous days news about Moderna
Moderna says U.S. to buy 100 million additional vaccine doses. According to Bloomberg Quint on Fri Dec 11, "Moderna Inc. said the U.S. government exercised its option to buy 100 million additional doses of the company’s coronavirus vaccine candidate, doubling the amount of the shot it initially committed to purchase and easing concern that the U.S. could be left with a vaccine shortfall.", "Moderna shares gained 2.6% in late trading in New York. "
Take-two, occidental petroleum, Moderna: what to watch when the stock market opens today. According to The Wall Street Journal on Tue Dec 15, "-Shares of the vaccine maker Moderna were down 1% premarket. "
Moderna vaccine found safe, effective ahead of key FDA review. According to Bloomberg Quint on Tue Dec 15, "Between Pfizer and Moderna, Operation Warp Speed officials have said 20 million people in the U.S. are expected to get their first shots by year-end.", "Once the U.S. grants authorization, advisers to the Centers for Disease Control and Prevention must meet, as they did last week on Pfizer’s vaccine, to give Moderna’s shot the green light and provide offer specific recommendations for use and monitoring. "
Moderna vaccine found safe, effective before key FDA review. According to Bloomberg Quint on Tue Dec 15, "The FDA got a much deeper look at Moderna’s clinical-trial data than the numbers previously released to the public by the company. ", "Moderna’s vaccine isn’t yet approved in any other countries and hasn’t yet been used on anyone outside of a clinical trial."
Moderna shares up in premarket as FDA calls Covid-19 vaccine 'highly effective'. According to MarketWatch on Tue Dec 15, "Shares of Moderna Inc. gained 1.5% in premarket trading on Tuesday after the Food and Drug Administration said the company’s COVID-19 vaccine candidate is “highly effective” at preventing infections with the coronavirus. "
Canada to receive early access to Moderna Covid-19 vaccine. According to Business Insider on Tue Dec 15, "Today, the Honourable Anita Anand, Minister of Public Services and Procurement, announced that following successful negotiations and contingent on Health Canada authorization of the vaccine, Canada will be able to access 168,000 doses of the Moderna COVID-19 vaccine in December 2020.", "These are part of the guaranteed 40 million doses, and up to a total of 56 million doses, that Canada has secured through its existing agreement with Moderna. "
Moderna to offer covid shots to volunteers who got placebo. According to Bloomberg Quint on Tue Dec 15, "Moderna Inc. is preparing to offer its Covid-19 shot to trial participants who received a placebo in the final-stage study once the vaccine is authorized for emergency use in the U.S.", "Ray Jordan, a Moderna spokesman, confirmed the letter was being prepared."